Cantor Fitzgerald Reiterates Overweight on Quantinuum, Maintains $90 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 89.9%

Neg 0% Neu 89.9% Pos 0%

Cantor Fitzgerald analyst Troy Jensen reiterates Quantinuum (NASDAQ:QNT) with a Overweight and maintains $90 price target.